TIFA Antikörper (N-Term)
Kurzübersicht für TIFA Antikörper (N-Term) (ABIN955209)
Target
Alle TIFA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 58-88, N-Term
-
Spezifität
- This antibody detects TIFA / T2BP (N-term).
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Protein A column followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 58~88 amino acids from the N-terminal region of human TIFA
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))
-
Andere Bezeichnung
- TIFA / T2BP
-
Hintergrund
- Adapter protein which mediates the IRAK1 and TRAF6 interaction following IL-1 stimulation, resulting in the downstream activation of NF-kappa-B and AP-1 pathways. Induces the oligomerization and polyubiquitination of TRAF6, which leads to the activation of TAK1 and IKK through a proteasome-independent mechanism.Synonyms: Putative MAPK-activating protein PM14, Putative NF-kappa-B-activating protein 20, TRAF-interacting protein with FHA domain-containing protein A, TRAF2-binding protein
-
Gen-ID
- 92610
-
NCBI Accession
- NP_443096
Target
-